CD274 and breast carcinoma: To date, only a limited number of publications have addressed the possibility that PD-L1 would act in an autonomous manner in breast cancer cells; these reports have used PD-L1 down-regulation or inhibition and demonstrated intrinsic PD-L1 activities in a few aspects of malignancy [31,32,33,34].